143 related articles for article (PubMed ID: 2306197)
1. Reduced gluconeogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
Gorski JR; Weber LW; Rozman K
Arch Toxicol; 1990; 64(1):66-71. PubMed ID: 2306197
[TBL] [Abstract][Full Text] [Related]
2. Corticosterone decreases toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in hypophysectomized rats.
Gorski JR; Lebofsky M; Rozman K
J Toxicol Environ Health; 1988; 25(3):349-60. PubMed ID: 3184202
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma corticosterone levels and histopathology of the adrenals and thymuses in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
Gorski JR; Muzi G; Weber LW; Pereira DW; Iatropoulos MJ; Rozman K
Toxicology; 1988 Dec; 53(1):19-32. PubMed ID: 3201474
[TBL] [Abstract][Full Text] [Related]
4. Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats.
Weber LW; Lebofsky M; Stahl BU; Gorski JR; Muzi G; Rozman K
Toxicology; 1991 Feb; 66(2):133-44. PubMed ID: 1849669
[TBL] [Abstract][Full Text] [Related]
5. Key enzymes of gluconeogenesis are dose-dependently reduced in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
Weber LW; Lebofsky M; Greim H; Rozman K
Arch Toxicol; 1991; 65(2):119-23. PubMed ID: 2059151
[TBL] [Abstract][Full Text] [Related]
6. Altered regulation of adrenal steroidogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
DiBartolomeis MJ; Moore RW; Peterson RE; Christian BJ; Jefcoate CR
Biochem Pharmacol; 1987 Jan; 36(1):59-67. PubMed ID: 3026405
[TBL] [Abstract][Full Text] [Related]
7. Corticosterone modulates acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in male Sprague-Dawley rats.
Gorski JR; Rozman T; Greim H; Rozman K
Fundam Appl Toxicol; 1988 Oct; 11(3):494-502. PubMed ID: 3220219
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and distribution of [14C]glucose in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Weber LW; Greim H; Rozman KK
J Toxicol Environ Health; 1987; 22(2):195-206. PubMed ID: 3118052
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration.
Potter CL; Sipes IG; Russell DH
Toxicol Appl Pharmacol; 1983 Jun; 69(1):89-95. PubMed ID: 6134353
[TBL] [Abstract][Full Text] [Related]
10. Circadian alterations in prolactin, corticosterone, and thyroid hormone levels and down-regulation of prolactin receptor activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Jones MK; Weisenburger WP; Sipes IG; Russell DH
Toxicol Appl Pharmacol; 1987 Feb; 87(2):337-50. PubMed ID: 3824389
[TBL] [Abstract][Full Text] [Related]
11. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains.
Viluksela M; Unkila M; Pohjanvirta R; Tuomisto JT; Stahl BU; Rozman KK; Tuomisto J
Arch Toxicol; 1999 Aug; 73(6):323-36. PubMed ID: 10447560
[TBL] [Abstract][Full Text] [Related]
12. Intermediary metabolism of the mature rat following 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.
Christian BJ; Menahan LA; Peterson RE
Toxicol Appl Pharmacol; 1986 Apr; 83(2):360-78. PubMed ID: 3961820
[TBL] [Abstract][Full Text] [Related]
13. Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Gorski JR; Muzi G; Weber LW; Pereira DW; Arceo RJ; Iatropoulos MJ; Rozman K
Toxicol Pathol; 1988; 16(3):313-20. PubMed ID: 3057589
[TBL] [Abstract][Full Text] [Related]
14. Mode of metabolism is altered in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
Muzi G; Gorski JR; Rozman K
Toxicol Lett; 1989 Apr; 47(1):77-86. PubMed ID: 2711413
[TBL] [Abstract][Full Text] [Related]
15. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Christian BJ; Inhorn SL; Peterson RE
Toxicol Appl Pharmacol; 1986 Feb; 82(2):239-55. PubMed ID: 3945951
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intestinal glucose absorption in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Richter E; Hunder G; Forth W
Vet Hum Toxicol; 1992 Apr; 34(2):123-6. PubMed ID: 1509671
[TBL] [Abstract][Full Text] [Related]
17. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thermogenesis in brown adipose tissue of rats.
Weber LW; Haart TW; Rozman K
Toxicol Lett; 1987 Dec; 39(2-3):241-8. PubMed ID: 3686553
[TBL] [Abstract][Full Text] [Related]
18. Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Moore RW; Potter CL; Theobald HM; Robinson JA; Peterson RE
Toxicol Appl Pharmacol; 1985 Jun; 79(1):99-111. PubMed ID: 4049410
[TBL] [Abstract][Full Text] [Related]
19. Is a serotonergic mechanism involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced appetite suppression in the Sprague-Dawley rat?
Rozman K; Pfeifer B; Kerecsen L; Alper RH
Arch Toxicol; 1991; 65(2):124-8. PubMed ID: 2059152
[TBL] [Abstract][Full Text] [Related]
20. Digestible energy and efficiency of feed utilization in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Seefeld MD; Peterson RE
Toxicol Appl Pharmacol; 1984 Jun; 74(2):214-22. PubMed ID: 6740672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
